EMpagliflozin 864070-44-0 BI-10773
EMpagliflozin Basic information |
Product Name: | EMpagliflozin |
Synonyms: | EMpagliflozin;BI-10773;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol;EMpagliflozin/ BI-10773;EMPAGLIFLBZIN;(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxyMethyl)-tetrahydro-2H-pyran-3,4,5-triol;D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]M ethyl]phenyl]-, (1S)-;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol Empagliflozin BI 10773 |
CAS: | 864070-44-0 |
MF: | C23H27ClO7 |
MW: | 450.90928 |
EINECS: | |
Product Categories: | API;Inhibitors |
Mol File: | 864070-44-0.mol |
EMpagliflozin Chemical Properties |
bp | 665℃ |
density | 1.398 |
Fp | 356℃ |
Safety Information |
EMpagliflozin Usage And Synthesis |
Usage | Empagliflozin is a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats. |
EMpagliflozin Basic information |
Product Name: | EMpagliflozin |
Synonyms: | EMpagliflozin;BI-10773;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol;EMpagliflozin/ BI-10773;EMPAGLIFLBZIN;(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxyMethyl)-tetrahydro-2H-pyran-3,4,5-triol;D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]M ethyl]phenyl]-, (1S)-;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol Empagliflozin BI 10773 |
CAS: | 864070-44-0 |
MF: | C23H27ClO7 |
MW: | 450.90928 |
EINECS: | |
Product Categories: | API;Inhibitors |
Mol File: | 864070-44-0.mol |
EMpagliflozin Chemical Properties |
bp | 665℃ |
density | 1.398 |
Fp | 356℃ |
Safety Information |
EMpagliflozin Usage And Synthesis |
Usage | Empagliflozin is a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats. |
EMpagliflozin Basic information |
Product Name: | EMpagliflozin |
Synonyms: | EMpagliflozin;BI-10773;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol;EMpagliflozin/ BI-10773;EMPAGLIFLBZIN;(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxyMethyl)-tetrahydro-2H-pyran-3,4,5-triol;D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]M ethyl]phenyl]-, (1S)-;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol Empagliflozin BI 10773 |
CAS: | 864070-44-0 |
MF: | C23H27ClO7 |
MW: | 450.90928 |
EINECS: | |
Product Categories: | API;Inhibitors |
Mol File: | 864070-44-0.mol |
EMpagliflozin Chemical Properties |
bp | 665℃ |
density | 1.398 |
Fp | 356℃ |
Safety Information |
EMpagliflozin Usage And Synthesis |
Usage | Empagliflozin is a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats. |
CAS NO:84-65-1
CAS NO:82-24-6
CAS NO:84-51-5
CAS NO:128-93-8
CAS NO:82-38-2
CAS NO:117-79-3
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View